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Purpose: The aim of this study was to investigate the relationship between lower uri-
nary tract symptoms (LUTS) and risk factors for vascular diseases in a pop-
ulation-based cohort study, the Hallym Aging Study (HAS). 
Materials and Methods: Among the 1,520 participants in HAS, 280 men aged more than 
50 years, who underwent detailed health evaluations, including health-related ques-
tionnaires, evaluations of their medical history, and various life style factors, as well 
as clinical measurements, were included in the study. Vascular risk factors used in the 
present study including hypertension, diabetes mellitus, hyperlipidemia, and smoking 
and were assessed by medical history and clinical measurements. LUTS were assessed 
by validated questionnaires, the International Prostate Symptom Score (IPSS), and 
the relationship between LUTS and vascular risk factors was investigated. 
Results: Of the 280 men, 175 (62.5%) had moderate/severe LUTS (IPSS＞7) and 260 
(93%) had one or more vascular risk factors. The IPSS was similar in those with no 
(11.6±9.7) and one or two (11.5±8.5) vascular risk factors, but increased to 15.1±9.3 in 
those with 3 or more vascular risk factors (p＜0.05). The multiple logistic regression 
analysis, controlling for age and body mass index (BMI) showed that men with 3 or more 
vascular risk factors were 3 times more likely to have moderate/severe LUTS than men 
without vascular risk factors (p＜0.05). 
Conclusions: Men with risk factors for vascular diseases are more likely to have LUTS 
and these findings suggest that vascular risk factors play a role in the development 
of LUTS. 
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INTRODUCTION
Lower urinary tract symptoms (LUTS) are relatively com-
mon conditions in aging men, and they have been known 
to greatly affect the quality of life [1]. Bladder outlet ob-
struction (BOO) due to benign prostatic hyperplasia (BPH) 
has been considered to be one of the major causes of LUTS. 
As a matter of fact, however, it has been reported that there 
is a lack of significant correlation between prostate size and 
LUTS [2,3]. Based on these reports, it can be inferred that 
factors other than BPH are involved in the pathogenesis 
of LUTS. 
　Vascular diseases are presumed to be one of the causes 
which are responsible for the pathogenesis of LUTS, and 
it has also been reported that aging-related arthero-
sclerosis or endothelial dysfunction in the pelvic vascular 
system can cause bladder dysfunction [4].
　To date, in animal models, artherosclerosis-induced pel-
vic ischemia has been shown to cause functional and struc-
tural alteration of the bladder and some studies have re-
ported that LUTS are significantly correlated with risk fac-
tors which are closely related to vascular diseases, such as Korean J Urol 2010;51:477-482
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TABLE 1. Clinical characteristics of participants
Variables No. of participants %
Age (years) 70.8±8.1
　50-59   31 11.1
　60-69   57 20.4
　70-79 162 57.9
　80-89   30 10.7
IPSS 12.3±8.8
　0-7 105 37.5
　8-20 110 39.3
　21-35   65 23.2
No. vascular risk factors 1.8±1.0
　0  2 0   7 . 1
　1   97 34.6
　2 102 36.4
　3   49 17.5
　4  1 2   4 . 3
BMI 24.1±2.9
SBP (mmHg) 144.8±18.2
DBP (mmHg)   85.3±10.4
FBS (mg/dl) 105.2±32.9
Total cholesterol (mg/dl) 183.5±37.0
Triglyceride (mg/dl) 144.0±88.9
HDL-C (mg/dl)   51.1±25.5
　Hypertension 111 39.6
　DM   35 12.5
Medical history 
　Hyperlipidemia   11   3.9
　Smoking   79 28.2
Values are presented as Mean±SD. IPSS: International Prostate 
Symptom Score, BMI: body mass index, SBP: systolic blood pressure,
DBP: diastolic blood pressure, FBS: fasting blood sugar, HDL-C: 
high-density lipoprotein cholesterol, DM: diabetes mellitus
hypertension, diabetes mellitus (DM), hyperlipidemia, 
and smoking [5-7]. However, some studies on this question 
have reported contradictory results and in particular, 
there are no reports of an association between LUTS and 
vascular risk factors in a population-based study.
　To investigate the potential role of vascular risk factors 
and the combination of these factors for the development 
of LUTS, we analyzed the association between LUTS and 
vascular risk factors (hypertension, DM, hyperlipidemia, 
smoking) in a population-based study of aging men. 
MATERIALS AND METHODS
1. Study population
In the Hallym Aging Study (HAS) on the quality of life in 
elderly Korean people, conducted by the Institute for Aging 
Studies at Hallym University, a cohort was composed of 
2,519 people aged 45 years or older who were randomly se-
lected in Seoul, the national capital and largest city of 
South Korea, and Chuncheon, a large city of South Korea. 
Of these, the Chuncheon- based cohort was considered in 
the current study. The selection of the study populations 
can be summarized as follows: 
　Of the 1,408 study sectors, which were classified based 
on the 2,000 population census in Chuncheon City, 200 
were randomly selected. In accordance with the proportion 
of the population aged 45 years or older from the individual 
Eup/ Myeon/Dong (Korean neighborhood and sub-neigh-
borhood classifications), the number needed for the study 
population was determined. Based on a list of study pop-
ulation that were selected for the current study, study par-
ticipants were systematically sampled. At this time, the 
number of study population was determined in such a man-
ner that 30% of the study population should be aged be-
tween 45 and 64 years and 70% should be aged 65 years or 
older with consideration of the effects of a long-term fol-
low-up study as well as the calculation of stable epidemio-
logical parameters. Of these, 1,520 people who responded 
to the primary panel survey, underwent a second in-depth 
study about health and psychology. Of the cohorts who vis-
ited Chuncheon Sacred Heart Hospital, underwent an in-
terview and a clinical test, and completed a health ques-
tionnaire, 280 male patients aged 50 years or older were 
enrolled in the current study.
2. The assessment of LUTS
In all the study participants, LUTS were assessed using a 
validated questionnaire yielding the International Prostate 
Symptom Score (IPSS), and the participants were classi-
fied into three categories according to their IPSS: mild (IPSS
≤7), moderate (IPSS 8-19), and severe (IPSS≥20) [8].
3. The assessment of vascular risk factors
Risk factors for vascular diseases used in the present study 
included hypertension, DM, hyperlipidemia, and smoking. 
To assess vascular risk factors, a detailed medical history 
questionnaire was completed by all the study participants. 
This was followed by blood pressure monitoring and hema-
tologic tests. Blood pressure was measured by an experi-
enced family medicine physician in such a condition that 
stability was maintained for more than ten minutes and ve-
nous blood was sampled following a 12-hour fast. Then, 
fasting blood sugar, total cholesterol, and triglyceride were 
measured.
　The presence of hypertension, DM, and hyperlipidemia 
were defined as cases in which there were medical histories 
or abnormal findings from the blood pressure and hemato-
logic tests based on criteria proposed by the National 
Cholesterol Education Program Adult Treatment Panel III 
(NCEP-ATP III) [9]. Smokers were defined as participants 
who annually smoked more than 400 cigarettes.
4. Data analysis
Statistical analysis was performed using SPSS 15.0 for 
Windows. Among the age groups, comparisons were made 
for the severity of LUTS and the number of vascular risk 
factors using a Mantel-Haenszel chi-square test. The dif-
ferences in IPSS according to the number of vascular risk 
factors were assessed by using one-way ANOVA, and mul-Korean J Urol 2010;51:477-482
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FIG. 1. (A) Prevalence and severity of lower urinary tract symptoms. (B) Vascular risk factors (VRF) in different age groups of the 
study population.
FIG. 2. The International Prostate Symptom Score (IPSS) accor-
ding to the number of vascular risk factors (VRF).
tiple regression analysis was used to describe the impact 
of vascular risk factors on LUTS. A value of p＜0.05 was 
considered statistically significant.
RESULTS
1. Study population
A total of 280 men, aged 50 to 87 years, were included in this 
study. The mean age was 70.8±8.1 years. Of these 280 men, 
31 (11.1%) were 50-59 years, 57 (20.4%) were 60-69 years, 
162 (57.9%) were 70-79 years and 30 (10.7%) were 80 years 
or older. The mean IPSS and the number of vascular risk 
factors were 12.3 and 1.8, respectively. Baseline character-
istics of study participants are summarized in Table 1.
2. Prevalence and severity of LUTS and vascular risk fac-
tors
Of the 280 men, 175 (62.5%) had moderate/severe LUTS 
(IPSS＞7) and 260 (93%) had one or more vascular risk 
factors.
　The prevalence of moderate/severe LUTS was 48.4%, 52.6%, 
67.3%, and 70%, respectively, among those aged 50 to 59, 
60 to 69, 70 to 79, and 80 years or older. The prevalence and 
severity of LUTS increased statistically significantly with 
age (Mantel-Haenszel chi-square test, p＜0.001) (Fig. 1).
　In each age group, the prevalence of participants with no 
vascular risk factors was 6.5%, 8.8%, 5.6%, and 13.3%, that 
with 1-2 vascular risk factors was 64.5%, 68.4%, 74.7%, and 
63.3%, and that with 3-4 vascular risk factors was 29%, 
22.8%, 19.7%, and 23.4%, respectively. There was no sig-
nificant difference in the number of vascular risk factors 
among the age groups (Mantel-Haenszel chi-square test, 
p＞0.05) (Fig. 1). 
3. IPSS according to the number of vascular risk factors
The mean IPSS in men with no vascular risk factors, 1-2 
vascular risk factors, and 3-4 vascular risk factors was 
11.6±9.7, 11.5±8.5, and 15.1±9.3, respectively and the 
mean IPSS in men with 3-4 vascular risk factors was sig-
nificantly higher than that with no or 1-2 vascular risk fac-
tors (ANOVA, p＜0.05) (Fig. 2). 
4. Correlation between IPSS and vascular risk factors
When adjusting for age and body mass index (BMI) in mul-
tiple linear regression analysis, none of the individual vas-
cular risk factors, that is, hypertension, DM, hyperlipidemia, 
or smoking, was shown to be independently correlated with 
IPSS (Table 2), but the number of vascular risk factors was 
significantly correlated with IPSS (Beta=2.90, p=0.003) 
(Table 3). 
5. Association between LUTS and vascular risk factors
When adjusting for age and BMI in multiple logistic re-
gression analysis, none of the individual vascular risk fac-
tors was shown to be associated with the presence of moder-
ate/severe LUTS (Table 4). However, men with 3 or more 
vascular risk factors were 3 times more likely to have mod-Korean J Urol 2010;51:477-482
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TABLE 3. Multiple linear regression analysis of the number of 
vascular risk factors affecting IPSS
Beta Standard error p-value
Age 0.32 0.06 ＜0.001
BMI  −0.12 0.18 0.485
No. of vascular risk factors 2.90 0.98 0.003
IPSS: International Prostate Symptom Score, BMI: body mass index
TABLE 2. Multiple linear regression analysis of individual vascular
risk factors affecting IPSS
Beta Standard error p-value
Age 0.32 0.66 ＜0.001
BMI  −0.13 0.19 0.478
Hypertension 1.87 1.62 0.249
Diabetes mellitus 0.99 1.14 0.390
Hyperlipidemia 0.86 1.08 0.429
Smoking 0.90 1.18 0.443
IPSS: International Prostate Symptom Score, BMI: body mass index
TABLE 4. Multiple logistic regression results for relative risk of 
moderate/severe LUTS by age, BMI, and individual vascular 
risk factors
Moderate/severe 
LUTS odds ratio 
(95% confidence interval)
p-value
Age 1.04 (1.01-1.08) 0.009
BMI 0.94 (0.86-1.03) 0.197
Hypertension 2.16 (0.99-4.68) 0.050
Diabetes mellitus  1.04 (0.60-1.82) 0.886
Hyperlipidemia 0.97 (0.57-1.64) 0.904
Smoking 1.15 (0.65-2.06) 0.628
LUTS: lower urinary tract symptoms, BMI: body mass index
TABLE 5. Multiple logistic regression results for relative risk of 
moderate/severe LUTS by age, BMI, and number of vascular 
risk factors
Moderate/severe 
LUTS odds ratio 
(95% confidence interval)
p-value
Age 1.05 (1.02-1.08) 0.004
BMI 0.94 (0.86-1.03) 0.155
Vascular
 risk factors
01
1-2 1.6 (0.62-4.22) 0.321
3-4 3.6 (1.19-10.62) 0.024
LUTS: lower urinary tract symptoms, BMI: body mass index
erate/severe LUTS than men without vascular risk factors 
(OR=3.6, 95% CI 1.19-10.62, p=0.024) (Table 5). 
DISCUSSION
LUTS are relatively common conditions in the field of urol-
ogy, and it is well established that the prevalence of LUTS 
increases with age. Rosen et al conducted a large-scale 
study in 12,815 men aged 50-80 years from six countries 
[10]. According to this study, the prevalence of moder-
ate/severe LUTS was 22% in men aged 50-59 years, but it 
was significantly higher (45.3%) in men aged 70-80 years. 
Also in Korea, according to a study that was conducted in 
1,356 men aged between 40 and 79 from Seoul and its sub-
urban areas, the prevalence of moderate/severe LUTS in-
creased with age (10%, 16%, 29%, and 45% in each age 
group) [11]. Also in our series, as shown in previous reports, 
the prevalence of moderate/severe LUTS increased sig-
nificantly with age.
　In aging men with LUTS, BOO due to BPH has been con-
sidered one of the major causes. As a matter of fact, how-
ever, the lack of a relationship between prostate size and 
LUTS is well established, and BOO was reported to be only 
a minor determinant of LUTS severity [2,3]. It is therefore 
presumed that factors beside prostate enlargement and 
BOO contribute to the development and severity of LUTS.
　The pathogenesis of LUTS is considered to be multi-
factorial, in which age-related changes of bladder structure 
and function seem to play a central role [12-16]. Vascular 
diseases such as artherosclerosis and endothelial dysfunction 
in the pelvic vascular system are one of the possible mecha-
nisms contributing to bladder dysfunction with age [4]. 
　In recent years, many studies have reported that LUTS 
are closely associated with erectile dysfunction and most 
of these studies have also presumed that vascular alter-
ation is a cause of the correlation [10,17,18].
　Some animal studies have reported that pelvic ischemia 
causes the structural and functional alteration of the blad-
der [5-7]. Clinically, hypertension, DM, hyperlipidemia, 
and smoking are representative risk factors for vascular 
diseases. These risk factors are known to increase the risk 
of developing artherosclerosis by 1.8-4.5 times [19,20]. To 
date, several studies have investigated the correlation be-
tween LUTS and these risk factors. Michel et al found a sig-
nificant age-independent association between the severity 
of LUTS and the presence of hypertension [21], and Joseph 
et al conducted a population-based study (Flint Men’s 
Health Study) in 708 men aged 40 years or older. These au-
thors reported that hypertension was a risk factor for LUTS 
[22]. Unlike these reports, however, there are also some re-
ports that hypertension is not associated with LUTS 
[23,24]. Also, in our series, there was a closer relationship 
between moderate/severe LUTS and hypertension than 
with other vascular risk factors such as DM, hyperlipidemia, 
and smoking, but these results did not reach a statistical 
significance (p=0.05). Both DM and smoking were well 
known risk factors of vascular diseases. Joseph et al and 
Seim et al reported that these two risk factors were closely 
associated with LUTS [22,25]. According to Rohrmann et 
al, however, following the Third National Health and 
Nutrition Examination Survey (NHANES III) which was Korean J Urol 2010;51:477-482
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conducted in 2,797 men aged 60 years or older, there was 
no significant correlation between smoking and LUTS [26]. 
Besides, Ponholzer et al also reported that vascular risk 
factors such as DM and smoking had no significant correla-
tion with IPSS [27]. In our study, none of the four vascular 
risk factors was shown to be independently correlated with 
LUTS. As described here, according to studies on the asso-
ciation between a single vascular risk factor and LUTS, no 
consistent results have been reported, and based on these 
results, it is presumed that a single vascular risk factor may 
be somewhat insufficient to influence LUTS. For this rea-
son, the current study attempted to investigate the associa-
tion between not only a single vascular risk factor but also 
the combination of these factors and LUTS.
　To date, as shown in the current study, two studies have 
been conducted to investigate the association between the 
number of vascular risk factors and LUTS. In association 
with this, Gibbons et al retrospectively analyzed 237 pa-
tients with prostate cancer who underwent radical prosta-
tectomy and thereby evaluated the correlation between the 
number of vascular risk factors and IPSS. These authors 
reported that IPSS increased significantly as the number 
of vascular risk factors increased [28]. According to a recent 
study examining the correlation between vascular risk fac-
tors and LUTS in 1,724 men and 812 women, women with 
1 or more vascular risk factors had a higher IPSS than those 
without a risk factor. In men, however, the IPSS was identi-
cal in those with no and 1 vascular risk factor, and increased 
significantly in those with 2 or more risk factors [27]. These 
results were similar to our finding that IPSS was sig-
nificantly higher in men with 3 or more vascular risk fac-
tors than those without a risk factor. As described here, the 
impact of vascular risk factors on LUTS in men was only 
present in those with more than 2 or 3 risk factors; this 
might be because BPH plays a important role in the devel-
opment of LUTS, and this observation might explain the 
fact that the results of numerous studies assessing the role 
of single vascular risk factors such as hypertension or 
smoking status on LUTS in men were contradictory. 
　Hypertension, DM, and smoking are well known risk fac-
tors for vascular diseases such as artherosclerosis. Via dif-
ferent paths from vascular diseases, however, they might 
also have an impact on LUTS. Increased sympathetic activ-
ity and/or α1-adrenoreceptor activity might be a common 
pathway for both hypertension and LUTS. Increased α1-a-
drenoreceptor activity might also explain the improve-
ment in LUTS with the use of α1-adrenoreceptor antago-
nist, despite the lack of objective improvement in BOO. DM 
may also induce LUTS through detrusor underactivity or 
sensory neuropathy. Smoking increases sympathetic 
nervous system activity and may contribute to LUTS via 
an increase in the tone of the prostate. For this reason, to 
understand more exactly the potential role of vascular dis-
eases in the development of LUTS, further studies are war-
ranted to investigate the association between LUTS and 
the direct indicators for vascular diseases such as in-
tima-media thickness of the carotid/iliac artery as well as 
vascular risk factors.
　The current study is a population-based cohort study 
that was conducted by selecting study participants in ac-
cordance with the proportion of population in a relatively 
larger-scale community-based population. To date, most 
studies on the association between LUTS and vascular risk 
factors have also been conducted in a smaller number of pa-
tients or those who visited outpatient clinics for a regular 
medical check-up, which therefore discloses the limitation 
that their results cannot be generalized.
　As described earlier, according to some studies reporting 
a correlation between LUTS and vascular risk factors, 
there is a close relationship between the two conditions. 
But most of these studies, including the current one, have 
a cross-sectional design based on the statistics collected at 
a certain point in time. These cross-sectional studies are 
not sufficient to clarify whether vascular risk factors in-
duce LUTS or whether two different conditions simply oc-
cur as a result of the common etiology. That is, a causal rela-
tionship between the two conditions remains obscure. To 
date, no studies have investigated the time-dependent cor-
relations between the two conditions in a single cohort. The 
current study was based on a cohort study, the Hallym 
Aging Study about the quality of life in Korean elderly peo-
ple, which has been conducted by the Institute for Aging 
Studies at Hallym University from 2003 to the present. 
Such a longitudinal study will then disclose. This will then 
disclose a more definite causal relationship between LUTS 
and vascular risk factors.
CONCLUSIONS
In a population-based cohort study of aging men, men with 
risk factors for vascular disease are more likely to have 
moderate/severe LUTS than men with no vascular risk fac-
tors and these findings suggest that vascular risk factors 
play a role in the development of LUTS.
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